About Asimov
Asimov is a Healthcare company based in Boston (United States) founded in 2017. Provider of integrated suite for advanced genetic design and manufacturing. Asimov has raised $209.4 million across 9 funding rounds from investors including Fidelity Investments, CPP Investments and KdT Ventures. The company has 87 employees. Its website asimov.com draws about 61 thousand monthly visits. Asimov offers products and services including CHO Edge System, LV Edge System, AAV Edge System, and Design Software. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is ASIMOV INC. Its competitors include Amyris, AskBio and Ginkgo Bioworks; 3 of its 3 listed competitors have raised funding.
Company details
Asimov was founded in 2017 and is headquartered in Boston, United States. An end-to-end platform is offered in the synthetic biology sector, combining computational tools with biological engineering. Engineered host cells, genetic parts libraries, and design software are provided as key components. Cell line development, genetic construct design, and data analysis are enabled through the system, with operations centered on biotechnology applications.
- Headquarters Boston, United States
- Employees 87
- SectorsHealthcare
- Website asimov.com
- Social LinkedIn X
- Legal Name Asimov Inc
- Total Equity Funding$209.4M (USD)
in 9 rounds
- Latest Funding Round$175M (USD), Series B
Jan 2023
- InvestorsFidelity Investments
& 10 more
- Employee Count87
Products & Services of Asimov
Asimov offers a comprehensive portfolio of products and services, including CHO Edge System, LV Edge System, AAV Edge System, and Design Software.
System for producing biologics with high titers.
Enables lentiviral production for therapeutic applications.
Facilitates gene therapy payload design and production.
Cloud-based tool for simulating and optimizing genetic systems.
Funding Insights of Asimov
Asimov has successfully raised a total of $209.4M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $175 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $209.4M
- Total Rounds 9
- Last Round Series B — $175M
- First Round $11.71M
(Apr 2017)
- Investors Count 11
All 9 funding rounds of Asimov with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $175M | Series B | – | CPP Investments | |
| Jun 2020 | $25M | Series A | – | Horizons Ventures | – |
| May 2019 | $6.86M | Post-IPO | – | – | – |
| Apr 2018 | $3.65M | Post-IPO | – | – | |
| Mar 2018 | $3.11M | Post-IPO | – | – | |
| Dec 2017 | $4.7M | Seed | – | a16z | |
| Dec 2017 | $2.3M | Post-IPO | – | – | – |
| May 2017 | $4.7M | Seed | – | a16z | |
| Apr 2017 | $11.71M | Post-IPO | – | – |
11 investors in total: 11 institutional.
Investors in Asimov
Asimov has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, CPP Investments and KdT Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in frontier science ventures. | kdtvc.com | Black Mountain, United States | ||
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Early-stage centric tech-focused VC firm investing in the US | pillar.vc | Boston, United States | ||
Venture capital investments in technology sectors are handled by Andreessen Horowitz. | a16z.com | |||
Horizons Ventures is focused on investing in deep science and technology. | horizonsventures.com | Hong Kong, China | ||
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
AME Cloud Ventures is focused on investing in data-driven technology companies. | amecloudventures.com | Palo Alto, United States | ||
Pension fund assets are managed for sustainable long-term growth. | 1997 | cppinvestments.com | Toronto, Canada | |
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
| gravitassecurities.com |
Investor details for Asimov
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Asimov
16 people are tracked at Asimov (8 in leadership, 5 in board & advisors, 3 in team); the tracked headcount is 87.
| Name | Role | Group |
|---|---|---|
Julie Andriolo | VP, Finance | Leadership |
Jamie Freeman | Senior Director, Business Development & Commercial Strategy | Leadership |
Alec Nielsen | Co-Founder & CEO | Leadership |
Kevin Smith | Head, Technology Development | Leadership |
D. Ben Gordon | Chief Innovation Officer | Leadership |
Alexis Sloane | Director Of People Operations | Leadership |
Martín Cárcamo Behrens | Sr. Director Commercial Product Strategy | Leadership |
Ashwin Rajput | Vice President Strategic Partnerships | Leadership |
Paul McCracken | Board Member | Board & advisors |
Raja Srinivas | Co-Founder | Board & advisors |
Douglas Densmore | Co-Founder | Board & advisors |
Christopher Voigt | Co-Founder | Board & advisors |
Jorge Conde | Board Member | Board & advisors |
Stephen Von Stetina | Principal Scientist | Team |
Gaelle Severe | Office Manager | Team |
Jenny Breselow | Talent Acquisition Lead | Team |
Complete people profiles for Asimov
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Asimov
3 dated milestones of Asimov across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Asimov is founded.
- Funding First funding round of $11.7M.
- Funding Latest funding round, Series B, of $175.0M.
Competitors of Asimov
Asimov has 3 listed competitors in our database, 3 of them funded. They include Amyris, AskBio and Ginkgo Bioworks.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| askbio.com | 2001 | Durham, United States | $235M | Gene and protein therapies are developed for treating various diseases. | ||
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. |
Detailed competitors of Asimov
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Asimov
The website of Asimov (asimov.com) receives about 61.3K visits a month.
- Monthly visits61.3K
▲ 13.9% vs previous month
Websites whose visitors overlap most with Asimov. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| unchainedlabs.com | 100% | 26.8K | #1,090,394 | View details | |
| origene.com | 97% | 122.1K | #329,769 | View details | |
rsscience.com | rsscience.com | 92% | #1,210,000 | – | |
| futurehouse.org | 90% | 84.3K | #454,581 | View details | |
genengnews.com | genengnews.com | 90% | #281,744 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Asimov
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Asimov (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Asimov
Complete news archive for Asimov
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asimov
Asimov was founded in 2017.
Asimov is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Asimov is a funded company, having raised a total of $209.4M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $11.71M, raised on Apr 2017.
Asimov has 87 employees.
Asimov was founded in 2017 and is headquartered in Boston, United States. An end-to-end platform is offered in the synthetic biology sector, combining computational tools with biological engineering. Engineered host cells, genetic parts libraries, and design software are provided as key components. Cell line development, genetic construct design, and data analysis are enabled through the system, with operations centered on biotechnology applications.
Asimov's top competitors include Amyris, AskBio and Ginkgo Bioworks.
Asimov offers CHO Edge System, LV Edge System, AAV Edge System, and Design Software.
Asimov has 11 investors. Key investors include Fidelity Investments, CPP Investments, KdT Ventures, Casdin Capital, and Pillar VC.
Asimov operates through Asimov Inc.